115
Views
0
CrossRef citations to date
0
Altmetric
Articles

Assessment of clinical chemistry and hematological parameters in female Sprague-Dawley rats following a 7-day oral exposure to three different species of Echinacea

ORCID Icon, ORCID Icon &

References

  • CRN. https://www.crnusa.org/newsroom/crn-reveals-survey-data-2022-consumer-survey-dietary-supplements. 5. August 2023.
  • Smith T, Majid F, Eckl V, Reynolds CM. Herbal supplement sales in US increase by record-breaking 17.3% in 2020. HerbalGram. 2021;131:52–65.
  • Luettig B, Steinmüller C, Gifford GE, Wagner H, Lohmann-Matthes ML. Macrophage activation by the polysaccharide arabinogalactan isolated from plant cell cultures of Echinacea purpurea. J Natl Cancer Inst. 1989;81(9):669–675. doi:10.1093/jnci/81.9.669.
  • Stimpel M, Proksch A, Wagner H, Lohmann-Matthes ML. Macrophage activation and induction of macrophage cytotoxicity by purified polysaccharide fractions from the plant Echinacea purpurea. Infect Immun. 1984;46(3):845–849. doi:10.1128/iai.46.3.845-849.1984.
  • Yu D, Yuan Y, Jiang L. Anti-inflammatory effects of essential oil in Echinacea purpurea L. Pak J Pharm Sci. 2013;26:403–408.
  • Chicca A, Raduner S, Pellati F, et al. Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extracts. Int Immunopharmacol. 2009;9(7–8):850–858. doi:10.1016/j.intimp.2009.03.006.
  • LaLone CA, Hammer KD, Wu L, et al. Echinacea species and alkamides inhibit prostaglandin E(2) production in RAW264.7 mouse macrophage cells. J Agric Food Chem. 2007;55(18):7314–7322. doi:10.1021/jf063711a.
  • Chicca A, Pellati F, Adinolfi B, et al. Cytotoxic activity of polyacetylenes and polyenes isolated from roots of Echinacea pallida. Br J Pharmacol. 2008;153(5):879–885. doi:10.1038/sj.bjp.0707639.
  • DSHEA. https://ods.od.nih.gov/About/DSHEA_Wording.aspx. 06 August 2023.
  • Dickinson A. History and overview of DSHEA. Fitoterapia. 2011;82(1):5–10. doi:10.1016/j.fitote.2010.09.001.
  • Marrone CM. Safety issues with herbal products. Ann Pharmacother. 1999;33(12):1359–1362. doi:10.1345/aph.19097.
  • Mengs U, Clare CB, Poiley JA. Toxicity of Echinacea purpurea. Acute, subacute and genotoxicity studies. Arzneimittelforschung. 1991;41(10):1076–1081.
  • Gallo M, Sarkar M, Au W, et al. Pregnancy outcome following gestational exposure to echinacea: a prospective controlled study. Arch Intern Med. 2000;160(20):3141–3143. doi:10.1001/archinte.160.20.3141.
  • Saunders PR, Smith F, Schusky RW. Echinacea purpurea L. in children: safety, tolerability, compliance, and clinical effectiveness in upper respiratory tract infections. Can J Physiol Pharmacol. 2007;85(11):1195–1199. doi:10.1139/Y07-103.
  • Jawad M, Schoop R, Suter A, Klein P, Eccles R. Safety and efficacy profile of Echinacea purpurea to prevent common cold episodes: A randomized, double-blind, placebo-controlled trial. Evid Based Complement Alternat Med. 2012;2012:841315–841317. doi:10.1155/2012/841315.
  • Huntley AL, Thompson Coon J, Ernst E. The safety of herbal medicinal products derived from Echinacea species: a systematic review. Drug Saf. 2005;28(5):387–400. doi:10.2165/00002018-200528050-00003.
  • Ardjomand-Woelkart K, Bauer R. Review and assessment of medicinal safety data of orally used Echinacea Preparations. Planta Med. 2016;82(1–2):17–31. doi:10.1055/s-0035-1558096.
  • Kocaman O, Hulagu S, Senturk O. Echinacea-induced severe acute hepatitis with features of cholestatic autoimmune hepatitis. Eur J Intern Med. 2008;19(2):148. doi:10.1016/j.ejim.2007.04.014.
  • Mullins RJ. Echinacea-associated anaphylaxis. Med J Aust. 1998;168(4):170–171. doi:10.5694/j.1326-5377.1998.tb126773.x.
  • Giles JT, Palat CT, 3rd, Chien SH, Chang ZG, Kennedy DT. Evaluation of echinacea for treatment of the common cold. Pharmacotherapy. 2000;20(6):690–697. doi:10.1592/phco.20.7.690.35173.
  • Soon SL, Crawford RI. Recurrent erythema nodosum associated with Echinacea herbal therapy. J Am Acad Dermatol. 2001;44(2):298–299. doi:10.1067/mjd.2001.112219.
  • NTP. Testing Status of Echinacea purpurea extract M990067. https://ntp.niehs.nih.gov/go/ts-m990067. 27 August 2023.
  • NTP. Testing Status of Echinacea purpurea root extract 16001. https://ntp.niehs.nih.gov/go/ts-16001. 6. August 2023.
  • HMPC. https://www.ema.europa.eu/en/documents/herbal-monograph/final-european-union-herbal-monograph-echinacea-purpurea-l-moench-herba-recens_en.pdf. 06. August 2023.
  • Blumenthal M. The Complete German Commission E Monographs. Therapeutic guide to herbal medicines. Austin, Texas; 1999.
  • Nagumalli SK, Salley JT, Carstens JD. 1H-NMR-based chemometric analysis of echinacea species to predict effectors of myeloid progenitor stimulation. Analytica. 2024;5(1):28–53. doi:10.3390/analytica5010003.
  • Clayton JA, Collins FS. Policy: NIH to balance sex in cell and animal studies. Nature. 2014;509(7500):282–283. doi:10.1038/509282a.
  • Garber JC, Barbee RW, Bielitzki JT, et al. Guide for the Care and Use of Laboratory Animals. Washington DC: The National Academic Press; 2011: 8:220.
  • Sadeghipour A, Babaheidarian P. Making formalin-fixed, paraffin embedded blocks. Biobanking: Methods and Protocols. 2019:253–268.
  • Team RC. R: A Language and Environment for Statistical Computing. (No Title) 2023.
  • Vacca LL. Laboratory manual of histochemistry. (No Title)1985.
  • Ramasahayam S, Baraka HN, Abdel Bar FM, et al. Effects of chemically characterized fractions from aerial parts of Echinacea purpurea and E. angustifolia on myelopoiesis in rats. Planta Med. 2011;77(17):1883–1889. doi:10.1055/s-0031-1279990.
  • Islam J, Carter R. Use of Echinacea in upper respiratory tract infection. South Med J. 2005;98(3):311–318. doi:10.1097/01.SMJ.0000154783.93532.78.
  • Petterino C, Argentino-Storino A. Clinical chemistry and haematology historical data in control Sprague-Dawley rats from pre-clinical toxicity studies. Exp Toxicol Pathol. 2006;57(3):213–219. doi:10.1016/j.etp.2005.10.002.
  • Hoffmann WE, Everds N, Pignatello M, Solter PF. Automated and semiautomated analysis of rat alkaline phosphatase isoenzymes. Toxicol Pathol. 1994;22(6):633–638. doi:10.1177/019262339402200607.
  • Condie L, Daniel FB, Olson GR, Robinson M. Ten and ninety-day toxicity studies of chloropicrin in Sprague-Dawley rats. Drug Chem Toxicol. 1994;17(2):125–137. doi:10.3109/01480549409014306.
  • Michael B, Yano B, Sellers RS, et al. Evaluation of organ weights for rodent and non-rodent toxicity studies: a review of regulatory guidelines and a survey of current practices. Toxicol Pathol. 2007;35(5):742–750. doi:10.1080/01926230701595292.
  • Cattley RC, Cullen JM. Liver and gall bladder. In Wanda M. Haschek-Hock, Colin G. Rousseaux and Matthew A. Wallig, eds. Haschek and Rousseaux’s Handbook of Toxicologic Pathology. Amsterdam, Netherlands: Elsevier; 2013:1509–1566.
  • Liu B, Bell AW, Paranjpe S, et al. Suppression of liver regeneration and hepatocyte proliferation in hepatocyte‐targeted glypican 3 transgenic mice. Hepatology. 2010;52(3):1060–1067. doi:10.1002/hep.23794.
  • Cable EE, Finn PD, Stebbins JW, et al. Reduction of hepatic steatosis in rats and mice after treatment with a liver‐targeted thyroid hormone receptor agonist. Hepatology. 2009;49(2):407–417. doi:10.1002/hep.22572.
  • Whalan JE. A Toxicologist’s Guide to Clinical Pathology in Animals. Hematology, Clinical Chemistry, Urinalysis. Switzerland: Springer International Publishing. 2015.
  • Hoffman FA. Botanicals as "new" drugs: US development. Epilepsy Behav. 2015;52(Pt B):338–343. doi:10.1016/j.yebeh.2015.07.028.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.